LOUISE MARQUINO: Open Payments
NPI 1508372491 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,010 in 45 payments from 26 companies in 2025. Trend: 2023 $805 · 2024 $824 · 2025 $1,010
Food & beverage: $1,010
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $73 |
| Syndax Pharmaceuticals, Inc. | 3 | $72 |
| Daiichi Sankyo Inc. | 3 | $69 |
| SOBI, INC | 3 | $65 |
| Janssen Biotech, Inc. | 3 | $63 |
| JAZZ PHARMACEUTICALS INC. | 2 | $62 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $61 |
| Geron Corporation | 2 | $53 |
| Celgene Corporation | 2 | $50 |
| Incyte Corporation | 2 | $47 |
Products named: REVUFORJ, Vanflyta, RYLAZE, EPKINLY, RYTELO, REBLOZYL, Vonjo, ENJAYMO.
Industry payments across CO — which companies pay providers there.
